Interestingly, CD8+CD103+ TRMs often accumulate within fibrotic or stromal regions distant from the tumor epithelium, as seen in pancreatic cancer, suggesting that fibrosis and stromal architecture may physically restrict TRM access, functioning as a tumor immune-evasion mechanism (172). This evidence concerns the gene ITGAE and pancreatic neoplasm.